Revolutionary breast cancer from Ulm: carefully looked after, better healed!

Die Uniklinik Ulm revolutioniert die Brustkrebsbehandlung mit der INSEMA-Studie: weniger Operationen, individuelle Therapien und bessere Heilungschancen.
The Ulm University Hospital revolutionizes breast cancer treatment with the Insema study: fewer operations, individual therapies and better chances of recovery. (Symbolbild/NAGW)

Revolutionary breast cancer from Ulm: carefully looked after, better healed!

The University Hospital Ulm plays a crucial role in the reorganization of breast cancer treatments. As part of the important insema study, which revolutionizes the treatment methods for patients with breast cancer, new ways are taken. Insights into the study show that operations can be carried out more effectively and less stressful. The goal is to reduce the number of necessary interventions and offer more individual therapies that minimize both the risk of relapse and increase the chances of recovery. This is supported by the knowledge that the removal of lymph nodes in the armpits is not always necessary, as swr.de report.

A patient named Julia, who wants to remain anonymous, has benefited from this new method. Her diagnosis was made in 2024 and two days after her operation, she is optimistic. The treating doctor, Dr. Visnja Fink, head of the breast center, emphasizes the need for new international guidelines for breast cancer treatment. The new approach enables the tumor to remove the tumor itself, which leads to a faster healing process. The advantage of this technology lies in the lower invasiveness, which means that patients have less pain and a shorter hospital stay.

less operations - more individuality

The Insema study also proves that axillary operations as staging methods have so far not been able to provide sufficient evidence in the mortality of breast cancer. Instead, postoperative therapy could better depend on the biological properties of the tumor and not according to the condition of the lymph nodes, as the gbg.de shows. This could be relieved for many patients, since unnecessary and stressful interventions are avoided.

The study pursues the goal of proving that patients in the early stages of breast cancer without axillary surgery do not have to suffer any disadvantage in survival. For this purpose, patients are randomized between a waiver of Axilla surgery and an axillary sentinel lymph node biopsy. For many, this could herald a completely new chapter in their fight against cancer.

modern aftercare and support

In the Ulm breast center, around 900 breast operations are carried out annually, including many chemotherapy. Before these treatments, individual fabric analyzes are made to ensure an optimal therapeutic result. In addition, the patients are accompanied by specially trained nurses, the so -called Breast Care Nurses, who are at your side in this difficult time.

The results of the Insema study could bring a real turn in the aftercare of breast cancer patients. A new concept enables the smallest tumor cells to prove in the blood, which contributes to recognizing relapses at an early stage. Julia herself takes part in the survive study, which aims for better aftercare and looks optimistically into the future. Your experiences show that hope and progress can go hand in hand - with a healing rate of about 90% for breast cancer!

Details
OrtUlm, Deutschland
Quellen